Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Antibody binding geometry and affinity control inhibitory hFcγRIIB receptor signaling.
Journal: Immunity
Published: July 02, 2025
A "Function-First" Approach to Identify Regulatory T cell-Targeting Antibodies for Immunotherapy.
Journal: Cancer immunology research
Published: November 04, 2024
Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc.
Journal: Frontiers in immunology
Published: July 03, 2023
Reducing affinity as a strategy to boost immunomodulatory antibody agonism.
Journal: Nature
Published: February 22, 2022
Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environments.
Journal: Journal for immunotherapy of cancer
Published: December 08, 2021
TNF receptor agonists induce distinct receptor clusters to mediate differential agonistic activity.
Journal: Communications biology
Published: February 05, 2021
Domain binding and isotype dictate the activity of anti-human OX40 antibodies.
Journal: Journal for immunotherapy of cancer
Published: November 24, 2020
Isotype Switching Converts Anti-CD40 Antagonism to Agonism to Elicit Potent Antitumor Activity.
Journal: Cancer cell
Published: October 28, 2019
Shaving Is an Epiphenomenon of Type I and II Anti-CD20-Mediated Phagocytosis, whereas Antigenic Modulation Limits Type I Monoclonal Antibody Efficacy.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 07, 2017
Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ Receptors.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 04, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026